• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙型病毒性肝炎。对自然史及预防的研究重新审视。

Viral hepatitis, type B. Studies on natural history and prevention re-examined.

作者信息

Krugman S, Overby L R, Mushahwar I K, Ling C M, Frösner G G, Deinhardt F

出版信息

N Engl J Med. 1979 Jan 18;300(3):101-6. doi: 10.1056/NEJM197901183000301.

DOI:10.1056/NEJM197901183000301
PMID:758598
Abstract

Frozen serial serum specimens obtained from past studies on the natural history and prevention of Type B hepatitis in children were retested by radioimmunoassay for the following markers of hepatitis B infection: hepatitis B surface antigen (HBsAg) and antibody (anti-HBs), hepatitis B e antigen (HBeAg) and antibody (anti-HBe), and antibody to hepatitis B core antigen (anti-HBc). The interval between exposure and evidence of viremia (HBsAg) was as short as six days. HBsAg and HBeAg persisted for two to five months and occasionally for more than one year after recovery. After the disappearance of their respective antigens, anti-HBc and anti-HBs persisted for more than seven years and anti-HBe for one to two years. Treatment with hepatitis B immune globulin after exposure induced complete or partial protection or prolongation of the incubation period. Administration of heat-inactivated hepatitis B virus, MS-2 strain, to 29 children induced an inapparent infection in three, characterized by a transient appearance of HBsAg and HBeAg, and the persistence of anti-HBc, anti-HBe and anti-HBs for more than two years.

摘要

从过去关于儿童乙型肝炎自然史和预防的研究中获得的冷冻系列血清标本,通过放射免疫测定法重新检测乙型肝炎感染的以下标志物:乙型肝炎表面抗原(HBsAg)和抗体(抗-HBs)、乙型肝炎e抗原(HBeAg)和抗体(抗-HBe)以及乙型肝炎核心抗原抗体(抗-HBc)。暴露与病毒血症证据(HBsAg)之间的间隔短至6天。HBsAg和HBeAg在恢复后持续2至5个月,偶尔持续超过1年。各自抗原消失后,抗-HBc和抗-HBs持续超过7年,抗-HBe持续1至2年。暴露后用乙型肝炎免疫球蛋白治疗可诱导完全或部分保护或延长潜伏期。给29名儿童接种热灭活的乙型肝炎病毒MS-2株,3人发生隐性感染,其特征为HBsAg和HBeAg短暂出现,抗-HBc、抗-HBe和抗-HBs持续超过2年。

相似文献

1
Viral hepatitis, type B. Studies on natural history and prevention re-examined.乙型病毒性肝炎。对自然史及预防的研究重新审视。
N Engl J Med. 1979 Jan 18;300(3):101-6. doi: 10.1056/NEJM197901183000301.
2
[Viral markers of hepatitis A and B: main characteristics and clinical significance].[甲型和乙型肝炎病毒标志物:主要特征及临床意义]
Arq Gastroenterol. 1983 Jul-Sep;20(3):117-22.
3
Viral hepatitis type B: propects for active immunization.乙型病毒性肝炎:主动免疫的前景
Dev Biol Stand. 1975;30:363-7.
4
Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.抗乙型肝炎核心免疫球蛋白M在乙型肝炎病毒感染以及与丁型肝炎病毒、非甲非乙型肝炎病毒同时感染的血清学评估中的应用
Gastroenterology. 1983 Jul;85(1):163-7.
5
Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.对从出生开始接种重组乙型肝炎疫苗的青少年中乙型肝炎病毒感染防护的持续性:一项15年随访研究。
Pediatr Infect Dis J. 2008 Oct;27(10):881-5. doi: 10.1097/INF.0b013e31817702ba.
6
[Hbeag/Anti-hbe system and other markers for hepatitis b in a dialysis unit (author's transl)].透析单元中乙肝的HbeAg/抗-Hbe系统及其他标志物(作者译)
Quad Sclavo Diagn. 1980 Dec;16(4):349-55.
7
[HBeAg and Anti-HBe in various groups of acute hepatitis patients and carriers of HBsAg].[急性肝炎患者各亚组及乙肝表面抗原携带者中的乙肝e抗原和乙肝e抗体]
Boll Ist Sieroter Milan. 1977 Mar 31;56(1):74-8.
8
Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.台湾原发性肝细胞癌患者的乙肝病毒标志物
J Natl Cancer Inst. 1981 Mar;66(3):475-9.
9
Anti-HBc titers in HBeAg and anti-HBe positive asymptomatic HBsAg carriers.HBeAg和抗-HBe阳性无症状HBsAg携带者的抗-HBc滴度
Z Immunitatsforsch Immunobiol. 1978 Jun;154(3):208-17.
10
Viral hepatitis, type B (MS-2-strain). Further observations on natural history and prevention.乙型病毒性肝炎(MS-2 株)。关于自然史和预防的进一步观察。
N Engl J Med. 1973 Apr 12;288(15):755-60. doi: 10.1056/NEJM197304122881503.

引用本文的文献

1
Immunogenicity and Efficacy of Vaccination in People Living with Human Immunodeficiency Virus.人类免疫缺陷病毒感染者接种疫苗的免疫原性和疗效
Viruses. 2023 Aug 30;15(9):1844. doi: 10.3390/v15091844.
2
Barriers Against Hepatitis B Vaccination in High-Risk Adults: A Cross-Sectional Study.高危成年人乙型肝炎疫苗接种障碍:一项横断面研究。
Turk J Gastroenterol. 2022 May;33(5):427-433. doi: 10.5152/tjg.2022.21257.
3
The Heat Stability of Hepatitis B Virus: A Chronological Review From Human Volunteers and Chimpanzees to Cell Culture Model Systems.
乙型肝炎病毒的热稳定性:从人类志愿者和黑猩猩到细胞培养模型系统的时间顺序综述。
Front Cell Infect Microbiol. 2020 Feb 4;10:32. doi: 10.3389/fcimb.2020.00032. eCollection 2020.
4
The effectiveness of the national hepatitis B vaccination program 25 years after its introduction in Iran: a historical cohort study.国家乙型肝炎疫苗接种计划在伊朗引入 25 年后的效果:一项历史性队列研究。
Braz J Infect Dis. 2019 Nov-Dec;23(6):419-426. doi: 10.1016/j.bjid.2019.10.001. Epub 2019 Nov 1.
5
Challenges with hepatitis B vaccination of high risk adults - A pilot program.高危成年人乙型肝炎疫苗接种面临的挑战 - 一项试点计划。
Vaccine. 2019 Aug 14;37(35):5111-5120. doi: 10.1016/j.vaccine.2019.05.089. Epub 2019 Jul 11.
6
Dynamics of hepatitis B virus serum markers in an acute hepatitis B patient in the incubation phase.一名急性乙型肝炎潜伏期患者的乙肝病毒血清标志物动态变化
Clin J Gastroenterol. 2019 Jun;12(3):218-222. doi: 10.1007/s12328-018-0925-6. Epub 2018 Nov 21.
7
Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices.美国乙型肝炎病毒感染预防:免疫实践咨询委员会的建议。
MMWR Recomm Rep. 2018 Jan 12;67(1):1-31. doi: 10.15585/mmwr.rr6701a1.
8
Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report.免疫抑制治疗与乙型肝炎再激活风险:共识报告
Turk J Gastroenterol. 2018 May;29(3):259-269. doi: 10.5152/tjg.2018.18263.
9
Hepatitis B virus and its sexually transmitted infection - an update.乙型肝炎病毒及其性传播感染——最新进展
Microb Cell. 2016 Sep 5;3(9):420-437. doi: 10.15698/mic2016.09.527.
10
The one year effects of three doses of hepatitis B vaccine as a booster in anti-HBs-negative children 11-15 years after primary immunization; China, 2009-2011.2009 - 2011年在中国进行的研究:对初次免疫11 - 15年后抗-HBs阴性儿童接种三剂乙肝疫苗作为加强针的一年效果。
Hum Vaccin Immunother. 2015;11(5):1114-9. doi: 10.4161/21645515.2014.987001.